首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Prostate

缩写:PROSTATE

ISSN:0270-4137

e-ISSN:1097-0045

IF/分区:2.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引3133条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Fabian Falkenbach,Mattia Longoni,Andrea Marmiroli et al. Fabian Falkenbach et al.
Background: It is unknown how survival is prematurely curtailed by incidental prostate cancer (IPCa). We aimed to quantify the average years of life lost (YLL) due to IPCa. ...
Jiaye Shen,Aaron J Katz,Yahui Xie et al. Jiaye Shen et al.
Background: For patients with unfavorable intermediate or high risk localized prostate cancer receiving definitive radiotherapy, androgen deprivation therapy reduces recurrence and improves survival but is underutilized d...
Anna S Pollack,James D Brooks,Jonathan R Pollack Anna S Pollack
Background: Benign prostatic hyperplasia (BPH) leads to prostate enlargement and lower urinary tract symptoms that can resist treatment. A histologic hallmark of BPH is glandular epithelial hyperplasia with new ductal bra...
Leonardo Quarta,Maximilian Filzmayer,Michele Petix et al. Leonardo Quarta et al.
Introduction: Temporal trends of metastatic prostate cancer (mPCa) in the prostate-specific membrane antigen positron emission tomography (PSMA PET) era in the United States are not known. ...
Yunwu Hao,Qianjun Liang,Bin Liu et al. Yunwu Hao et al.
Purpose: This study aims to investigate the effects of holmium laser enucleation of the prostate (HoLEP) with proactive preservation of one lateral lobe (PLL-HoLEP) on urinary function and sexual function in patients with...
Miguel Ángel Gómez-Luque,Pedro De Pablos-Rodríguez,Daniel Adolfo Pérez-Fentes et al. Miguel Ángel Gómez-Luque et al.
Background and objective: Metastatic hormone-sensitive prostate cancer (mHSPC) exhibits heterogeneous progression patterns, with early progression to metastatic castration-resistant prostate cancer (mCRPC) within 12 month...
Chikao Aoyagi,Shintaro Aso,Masahiro Tachibana et al. Chikao Aoyagi et al.
Background: Pelvic ischemia has been found to be associated with lower urinary tract dysfunction; however, the impact of intraoperative prostate bed blood flow on postoperative lower urinary tract symptoms (LUTS) after ro...
Kohei Hashimoto,Kouji Izumi,Takashi Shima et al. Kohei Hashimoto et al.
Background: This study aimed to clarify whether variations in the lowest prostate‑specific antigen (PSA) level prior to the development of castration‑resistant prostate cancer (CRPC) influence the efficacy of subsequent...
Leonardo Quarta,Michele Petix,Maximilian Filzmayer et al. Leonardo Quarta et al.
Introduction: Randomized trials demonstrated improved survival in metastatic prostate cancer (mPCa) with the adoption of several systemic therapies. However, real-world data validating this effect and quantifying its magn...